Results 221 to 230 of about 154,795 (245)
Some of the next articles are maybe not open access.
Comparative analysis of the transcriptome of T2DM Bama mini-pigs with T2DM patients
International Journal of Diabetes in Developing Countries, 2021To compare the transcriptional differences between the T2DM-susceptible and T2DM-tolerant Bama mini-pigs and to determine the utility of Bama mini-pigs as an animal model for T2DM by comparing the transcriptomes of the animals with T2DM patients. The skeletal muscle transcriptomes of healthy Guangxi Bama mini-pigs (CON), T2DM pigs (T2D), and non-T2DM ...
Xueyu Yan +8 more
openaire +1 more source
Clinical inertia in management of T2DM
Primary Care Diabetes, 2010Diabetes is highly prevalent and serious chronic debilitating disease and reported to be the fourth main cause of death in Europe. Despite extensive evidence of benefits of tight glycemic control, large proportions of people with diabetes do not achieve target glycemic control.
Zafar, A, Davies, M, Azhar, A, Khunti, K
openaire +3 more sources
Dapagliflozin—redefining treatment of T2DM?
Nature Reviews Endocrinology, 2011Glycemic control for many patients with type 2 diabetes mellitus (T2DM) is elusive, and the adverse effects of treatment, including hypoglycemia and weight gain, are partially culpable. Until recently, glycosuria has been regarded only as a consequence of T2DM, but dapagliflozin employs glycosuria as a mechanism of treatment.
openaire +1 more source
T2DM remission — consensus on definition
Nature Reviews Endocrinology, 2021openaire +2 more sources